SAN BRUNO, Calif.--(BUSINESS WIRE)-- Numerate, Inc., a technology platform company that is leveraging proprietary algorithms and the power of cloud computing to radically transform the drug design process, will announce the award of a three-year contract by the Department of Defense through its Transformational Medical Technologies (TMT) Program. Numerate may receive up to $6.75 million under this new Defense Threat Reduction Agency (DTRA) contract to extend its pioneering data-driven drug design approach, applying modern machine-learning methods similar to those employed by Google, Amazon and Netflix to rapidly design new drugs with optimized safety, efficacy and dosing convenience.
|Congresswoman Jackie Speier|
|Jeremy Leffler, Bay Bio Chief Operating Officer|
|Guido Lanza, Numerate Chief Executive Officer|
|Nigel Duffy, Numerate Chief Technology Officer|
|Press conference announcing award of DTRA contract to Numerate|
|Numerate headquarters, 1150 Bayhill Drive, Suite 203, San Bruno, CA|
|Thursday, September 9, 2010, from 11:30 a.m. to 12 noon.|
|Presenters will provide brief overview of company technology, potential significance to healthcare industry, and importance of biotech innovation, both locally and nationally.|
Numerate is a privately held biotechnology company focused on making the drug design process more data-driven, efficient and predictable. Numerate’s technology platform combines advances in computer science and statistics with traditional medicinal chemistry approaches to address, in parallel, the factors that determine the success and failure of a drug candidate. Numerate applies this proprietary platform to design and develop small molecule therapeutics in collaboration with a variety of partners in the pharmaceutical, biotechnology, and academic fields. For more information, visit www.numerate.com.
for Numerate, Inc.
Carole Melis, 650-342-5686
KEYWORDS: United States North America California
INDUSTRY KEYWORDS: Technology Data Management Software Health Biotechnology Pharmaceutical Research Science